2 recruiting, 1 not yet recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow HFmrEF: new trials by email Literature Review of HFmrEF trials Research Report on HFmrEF
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Coffee Use, Physical Activity and Symptomatic Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction and an ICD Questionnaire - HFrEF - Heart Failure With Reduced Ejection Fraction, HFmrEF | Not yet recruiting | Jean-Benoît Le Polain de Waroux | 170 | 2026-10-01 | 2026-09-17 | |
| Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Combination therapy, Monotherapy - Combined Pre- and Post-capillary Pulmonary Hypertension, CpcPH | Phase 4 | Recruiting | Gachon University Gil Medical Center | 64 | 2025-11-24 | 2026-04-03 |
| US Benchmarking Clinical Study HFpEF - Heart Failure With Preserved Ejection Fraction, HFmrEF | Recruiting | eMyosound SAS | 150 | 2025-09-16 | 2025-10-20 |
Amyloid Neuropathies, Familial (1) · Heart Failure (1) · Hypertrophy, Left Ventricular (1)
Amyloid Neuropathies (1) · Amyloidosis (1) · Amyloidosis, Familial (1) · Cardiomegaly (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Heart Diseases (1) · Heredodegenerative Disorders, Nervous System (1) · Hypertrophy (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Neuromuscular Diseases (1)
Combined Modality Therapy (1) · Surveys and Questionnaires (1)
Gachon University Gil Medical Center (1) · Jean-Benoît Le Polain de Waroux (1) · eMyosound SAS (1)
Belgium (1) · South Korea (1) · United States (1)
Thierry Sarda (1)